Immupharma PLC has received a notification of major holdings from Lanstead Capital Investors LP. Lanstead Capital Investors LP has acquired voting rights in Immupharma PLC, resulting in a total of 22.28% of voting rights attached to shares. The previous notification showed a position of 7.97% of voting rights. The notification was made on September 5, 2023, and the issuer was notified on September 6, 2023.
The details of the resulting situation on the date the threshold was crossed or reached are as follows: 91,322,252 voting rights attached to ordinary shares, representing 22.28% of voting rights. There are no financial instruments with voting rights that may be acquired or have a similar economic effect.
Lanstead Capital Investors LP is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in Immupharma PLC. No additional information or details about proxy voting were provided in the notification.
The notification was completed in London on the date specified. Further information can be found on the Immupharma PLC website.